Unconfigured Ad
Collapse
X
-
No there is no publication associated with it. But people have compared it with other aligners in their works.
-
Thanks, seems there is not an associated publication for SMALT. There is?Originally posted by jshaik View PostThis aligner seem to address the issue of chimeric reads: http://www.sanger.ac.uk/resources/software/smalt/
I personally didnt try this yet but will try it next time I need to align something.
Leave a comment:
-
aligner from sanger
This aligner seem to address the issue of chimeric reads: http://www.sanger.ac.uk/resources/software/smalt/
I personally didnt try this yet but will try it next time I need to align something.
Leave a comment:
-
FASTQC of unmapped reads
If you give me your email I can send you FASTQC output of unmapped reads to know your opinion.
Bernardo
Leave a comment:
-
Sorry, I forgot to say that I have finally 25% mapping sequences (of 3 million). My reference sequence is a draft genome in 47 segments.
Leave a comment:
-
>1, If there is a PCR step, chimeric reads are not unexpected. Many polymerases, especially those assuming high fidelity, have strand displacement activity. The occurrence of chimeric reads depends on both polymerases and protocols.
Ok, I think I'm wasting money.
>2, Some chimeric reads may not be authentic ones. In this situation, I usually increase mapping stringency and found many of "chimeric" reads became single-hit ones.
I'm mapping only >Q20 reads. I've seen were and how they are mapping and they have 100% similarity in both hits. Sometimes there are three hits for one read.
>If your data has a profound depth, I don't think this will affect/bias your final result.
I have 800.000 sequences mapped to a 2 Mb prokaryotic genome. My mean read length is about 150 bp.
>The other way is to extract these chimeric reads only and do some trimming
I would like to finish my PhD, trimming is not feasible! So many chimeras.
>4, Finally, I assume you already done quality control prior to the align.
Of course, only >Q20 and trimming low quality 3' region.
Thank you, Bernardo
Leave a comment:
-
1, If there is a PCR step, chimeric reads are not unexpected. Many polymerases, especially those assuming high fidelity, have strand displacement activity. The occurrance of chimeric reads depends on both polymerases and protocols.
2, Some chimeric reads may not be authenic ones. In this situation, I usually increase mapping stringency and found many of "chimeric" reads became single-hit ones.
3, For remaining "true" chimeric reads, there are 2 ways to go. One is just to discard them (as shown in many previous publications where this issue is largely ignored). If your data has a profound depth, I don't think this will affect/bias your final result. The other way is to extract these chimeric reads only and do some trimming, re-aligned to see whether if they become single-hit reads, and finally combine all single hit reads for downstream analysis.
4, Finally, I assume you already done quality control prior to the align.
Leave a comment:
-
Hello fanx,
Thank you for your response.
1) Yes, there is a PCR step. We have used the hole transcriptome procedure described here 'Ion Total RNA-Seq Kit v2'
2) I used BWA for Illumina in Galaxy with default settings.
Leave a comment:
-
To answer your question, I need to know 1) is there any amplification step prior to the sequencing? 2) what's the aligner you used for mapping.
Leave a comment:
-
We have recently sequenced a bacterial transcriptome with 316 chip from IonTorrent (1.5 million sequences). After filtering low quality data and trimming adapters we noticed that only 51.33% sequences were mapped on reference genome. Looking for the unmapped sequences we can see that most of them are chimeric transcripts, so impossible mapping for them an also causing bias on results. Also many of the unmapped are sequences lacking homology in 20% of the starting sequence.
I would like to know your opinion about it.
Should I have to move to 454 or Illumina? Our Sequencing Department have no idea of why we have so many chimeras.
Thank you, Bernardo
Leave a comment:
-
Trost, Thanks your point. I made a search prior to the post, which found UCHIME. I didn't investigate it in detail because I guess UCHIME may need a high coverage, such as PCR amplicons. However, my RNA-Seq data is from human blood that is complicated with RNA from human genes, virus and fungi etc at low coverage.
One way I thought about is to split reads into 2 parts and then see if they turn to be single mapped reads. This spit can be done easily with current scripts but I worry about potential lose of information. To my knowledge, there is really no way to handle this issue.
I am using 454 and I think I should switch to Illumina. Short reads might be helpful.
Leave a comment:
-
UCHIME claims to be able to do some de novo chimera detection, or use bits of your known reference:
http://bioinformatics.oxfordjournals.../2194.abstract
Leave a comment:
-
Thanks. In fact, I know the problem is reads rather than the reference genome. I believe most reads are chimeric.
Leave a comment:
-
Doesn't it just mean that the read comes from a region of the genome that is repeated? So it aligns to all copies of the repeat?
Leave a comment:
-
Chimeric reads
Hello, my previous post seems very quiet. Here I raise this question in a different way.
I use Bowtie 2 to find many 454 reads are mapped >1 times. I believe these are chimeric reads due to the use of multiple stand displacement for initial amplification of minute amount DNA template. Is anyone aware of some tools that can split chimeric reads into single non-chimeric reads? Thanks a lot.
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
47 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
35 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
46 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
46 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Leave a comment: